The Clorox Company
NYSE:CLXHousehold & Personal Products
-$2.54 today
- Market cap
- $13.13B
- Beta
- 0.55
- P/E (TTM)
- 15.2
- EPS (TTM)
- $6.23
- Dividend yield
- 5.22%
Volume 2.16M
Average 2.84M
CLX Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
The Clorox CompanyNYSE: CLX
Goodwill · Q1 FY2027 · quarter ended Sep 2026
Goodwill rises 58.4% from a year ago
Goodwill stood at $1.94B at the end of Q1 FY2027, up 58.4% from a year earlier and down 0.1% from the prior quarter. Over 3 fiscal years it compounded at +15.8% a year.
Context
- Goodwill amounted to 24.8% of total assets at the end of Q1 FY2027, up 2.6 pp from a year earlier.
- Goodwill increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether goodwill keeps rising in the next quarterly balance sheet after a +58.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
USD · from the balance sheet
- Latest · FY2026
- 1.95B USD
- Year-over-year change
- +58.3%
- 4-year CAGR
- +5.7%
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 1.95B | +58.3% |
| FY2025 | 2025-06-30 | 1.23B | +0.1% |
| FY2024 | 2024-06-30 | 1.23B | -1.9% |
| FY2023 | 2023-06-30 | 1.25B | -19.6% |
| FY2022 | 2022-06-30 | 1.56B | — |
Goodwill vs competitors
How CLX compares with its peers on the latest reported figures
- Peers report in different currencies, so goodwill is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +58.4% is the highest of 11, against a peer median of -1.5%.
- Goodwill amounts to 24.8% of total assets for CLX, versus a peer median of 26.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $41.2B USD | -1.1% | +0.5% | 30.9% | |
| Dec 2025 | €17.7B EUR | -20.7% | -6.4% | 25.1% | |
| Sep 2026 | $9.25B USD | -2.0% | +1.2% | 34.7% | |
| Sep 2026 | $3.08B USD | -16.8% | -2.3% | 18.4% | |
| Sep 2026 | $2.67B USD | +0.9% | +2.7% | 28.5% | |
| Sep 2026 | $1.94B USD | +58.4% | +15.8% | 24.8% | |
| Jun 2026 | $1.9B USD | +0.0% | +0.3% | 37.3% | |
| Jun 2026 | $1.83B USD | -0.3% | -3.9% | 9.9% | |
| Mar 2026 | $1.13B USD | -14.9% | -0.8% | 32.1% | |
| Jun 2026 | $863.9M USD | -0.6% | -3.1% | 24.1% | |
| Feb 2026 | $472.28M USD | -60.1% | -23.8% | 22.3% | |
| Peer median (excluding CLX) | — | -1.5% | -1.6% | 26.8% | |
Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 183M | 367M | 202M | 167M | 143M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 681M | 688M | 695M | 821M | 791M |
| Inventory | 755M | 696M | 637M | 523M | 777M |
| Other Current Assets | 0 | 77M | 88M | 97M | 113M |
| Total Current Assets | 1.73B | 1.83B | 1.62B | 1.61B | 1.82B |
| Property, Plant & Equipment (Net) | 1.68B | 1.69B | 1.68B | 1.6B | 1.91B |
| Goodwill | 1.56B | 1.25B | 1.23B | 1.23B | 1.95B |
| Intangible Assets | 884M | 712M | 681M | 566M | 606M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 315M | 462M | 545M | 558M | 1.51B |
| Total Non-current Assets | 4.43B | 4.12B | 4.13B | 3.95B | 5.97B |
| Total Assets | 6.16B | 5.95B | 5.75B | 5.56B | 7.79B |
| Account Payables | 960M | 1.02B | 950M | 838M | 1.6B |
| Short-term Debt | 237M | 50M | 4M | 4M | 1.09B |
| Tax Payables | 0 | 121M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 176M | 262M | 190M | 179M | 0 |
| Total Current Liabilities | 1.78B | 1.92B | 1.57B | 1.92B | 2.77B |
| Long-term Debt | 2.47B | 2.48B | 2.48B | 2.48B | 3.98B |
| Deferred Tax Liabilities | 66M | 28M | 22M | 20M | 17M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 791M | 825M | 848M | 351M | 405M |
| Total Non-current Liabilities | 3.65B | 3.64B | 3.69B | 3.16B | 4.77B |
| Total Liabilities | 5.43B | 5.56B | 5.26B | 5.08B | 7.54B |
| Common Stock | 131M | 131M | 131M | 131M | 131M |
| Retained Earnings | 1.05B | 583M | 250M | 432M | 386M |
| Accumulated OCI | (479M) | (493M) | (155M) | (157M) | (157M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 173M | 168M | 164M | 161M | 162M |
| Total Equity | 729M | 388M | 492M | 482M | 252M |
| Total Debt | 3.1B | 2.92B | 2.9B | 2.88B | 5.52B |
| Net Debt | 2.92B | 2.56B | 2.7B | 2.71B | 5.38B |
The Clorox Company
NYSE:CLX
Intrinsic Alpha fair value
Locked
Current Price
$108.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.